PROSTAVISION Trademark

Trademark Overview


On Monday, July 26, 2021, a trademark application was filed for PROSTAVISION with the United States Patent and Trademark Office. The USPTO has given the PROSTAVISION trademark a serial number of 79327233. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, February 7, 2024. This trademark is owned by ABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH. The PROSTAVISION trademark is filed in the Pharmaceutical Products category with the following description:

Medical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations...
prostavision

General Information


Serial Number79327233
Word MarkPROSTAVISION
Filing DateMonday, July 26, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, February 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical and veterinary preparations for the diagnosis of diseases of the prostate; medical and veterinary preparations for the treatment of diseases of the prostate; medical and veterinary preparations for the diagnosis of cancer; medical and veterinary preparations for the treatment of cancer; dietetic foods and beverages for medical or veterinary purposes; chemical preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; chemical preparations for medical or pharmaceutical purposes for the diagnosis of cancer; chemical preparations for medical or pharmaceutical purposes for the treatment of cancer; biological preparations for medical or pharmaceutical purposes for the diagnosis of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the treatment of diseases of the prostate; biological preparations for medical or pharmaceutical purposes for the diagnosis of cancer; biological preparations for medical or pharmaceutical purposes for the treatment of cancer; preparations for use in medical diagnostic processes; preparations for use in medical diagnostic processes relating to the diagnosis of diseases of the prostate; preparations for use in medical diagnostic processes relating to the diagnosis of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameABX advanced biochemical compounds - Biomedizinische Forschungsreagenzien GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Wednesday, February 7, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, February 7, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, January 1, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, July 26, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 26, 2023FINAL REFUSAL E-MAILED
Wednesday, July 26, 2023FINAL REFUSAL WRITTEN
Thursday, June 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, June 21, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, December 5, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, December 5, 2022LETTER OF SUSPENSION E-MAILED
Monday, December 5, 2022SUSPENSION LETTER WRITTEN
Thursday, December 1, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 30, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 30, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 16, 2022CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Sunday, July 10, 2022CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, July 5, 2022REFUSAL PROCESSED BY IB
Wednesday, June 8, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, June 7, 2022REFUSAL PROCESSED BY MPU
Tuesday, May 3, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, May 2, 2022NON-FINAL ACTION WRITTEN
Sunday, May 1, 2022NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Saturday, March 19, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 18, 2022NON-FINAL ACTION WRITTEN
Tuesday, March 8, 2022ASSIGNED TO EXAMINER
Saturday, December 18, 2021APPLICATION FILING RECEIPT MAILED
Tuesday, December 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 13, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 2, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB